| 64 |
UDCA, the main ingredient of Ursa, has been proved to be effective for treatment of macular degeneration in an animal study |
2010-07-08 |
| 63 |
Daewoong’s URSA Tab.(200mg) adds indication for Hepatitis C |
2010-03-31 |
| 62 |
Daewoong Pharmaceutical Co. Ltd., introduced MIV-210, global new medicine for Hepatitis B |
2010-03-22 |
| 61 |
Daewoong, signs contract with Boehringer Ingelheim Korea |
2010-03-16 |
| 60 |
A new type of medicine for prostatic hypertrophy ‘OD Tablet’ launched |
2010-03-02 |
| 59 |
Next generation pain killers ‘DWP05195’, obtained approval of multiple medication clinical trial plans |
2010-02-10 |
| 58 |
URSA hits 0.1 million boxes in China only two months after launched |
2010-02-04 |
| 57 |
Daewoong Pharmaceutical Co. Ltd. enters the biggest medicine market of U.S.A |
2010-01-19 |
| 56 |
Daewoong signed contract for sale of ‘Epliga’, an incrementally modified drug against epilepsy |
2009-12-29 |
| 55 |
Daewoong to build a high tech plant in Chungju company city |
2009-12-14 |
